findmyKOL
Clinical trialNCT04422431CompletedPhase 2Interventional

Copper Concentration & Histopathologic Changes in Liver Biopsy in Participants With Wilson Disease Treated With ALXN1840

SponsorAlexion Pharmaceuticals, Inc.Enrollment31Wilson Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Research Site

    Toronto, Ontario, Canada

Denmark
  • Research Site

    Århus N, Denmark

New Zealand
  • Research Site

    Grafton, New Zealand

Russia
  • Research Site

    Moscow, Russia

  • Research Site

    Saint Petersburg, Russia

Singapore
  • Research Site

    Singapore, Singapore

Spain
  • Research Site

    Barcelona, Spain

  • Research Site

    Valencia, Spain

United Kingdom
  • Research Site

    London, United Kingdom

United States
  • Research Site

    Sacramento, California, United States

  • Research Site

    Ann Arbor, Michigan, United States

  • Research Site

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Dec 2020
Primary completion
21 May 2022
Completion
17 May 2023
Last update posted
18 Oct 2024
Registered enrollment
31
Registry id
NCT04422431

Cross-registrations

EU-CTR / CTIS (EudraCT)2019-003711-60

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.